After PA treatment, compared with the AD model group, the expression of phosphorylated NF‐κB/NF‐κB and phosphorylated IκBα/IκBα was significantly decreased, suggesting the inhibition of the NF‐κB pathway (Figure 4C,D). Here, NFKB1 is linked to Alzheimer disease.